Growth Metrics

Myomo (MYO) Net Cash Flow Growth (5y) (2021 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Myomo 44.63 Mn 26.23 Mn -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2025 -21.63%
Jun 30, 2025 -13.52%
Mar 31, 2025 -20.09%
Dec 31, 2024 164.60%
Sep 30, 2024 19.95%
Jun 30, 2024 16.67%
Mar 31, 2024 -20.40%
Dec 31, 2023 52.57%
Sep 30, 2023 18.68%
Jun 30, 2023 -6.21%
Mar 31, 2023 27.58%
Dec 31, 2022 -17.73%
Sep 30, 2022 -5.44%
Jun 30, 2022 -19.85%
Mar 31, 2022 -44.22%
Dec 31, 2021 57.11%
Sep 30, 2021 -50.76%